Singapore HSA Updates Therapeutic Product Registration Guidelines

As part of Singapore HSA’s ongoing initiatives to improve regulatory efficiency and enhance clarity in HSA’s regulatory requirements and processes, the Therapeutic Products Branch (TPB), Health Products Regulation Group of HSA, announced a list of updates to the guidance documents for therapeutic product registration, as well as changes made to the HSA’s online application form (PRISM Application Form).

For more details on the updates/changes, please visit the following link for HSA’s announcement:

To view the updated guidance documents for therapeutic product registration (including Appendices) referred to in HSA’s announcement, please visit the following websites:


Share on Linkedin Send to Email

Questions? Request more information from our specialists!

Contact Us

More News